SL
PALI icon

Siren LLC’s Palisade Bio PALI Stock Holding History

Siren LLC’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.18M Buy
+2,000,000
New +$3.94M 0.08% 93

Other funds holding PALI

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

Siren LLC's PALI Position: Q2 2026 in Review

Siren LLC opened a new position in Palisade Bio (PALI) in Q2 2026: 2,000,000 shares worth $4.18M. The stake represents 0.08% of the portfolio and ranks #93 among its holdings.

71 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • Siren LLC held 2,000,000 shares of Palisade Bio worth $4.18M as of Q2 2026.
  • Palisade Bio was a new Siren LLC position in Q2 2026.
  • Palisade Bio made up 0.08% of Siren LLC's portfolio in Q2 2026, its #93 holding.
  • 71 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Siren LLC's 13F filing for Q2 2026, filed 13 Aug 2026.